TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
AGC Biologics A/S
Closing information (x1000 DKK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
2,016,194
|
2,092,565
|
2,517,996 |
| Earnings before taxes |
-145,332
|
316,034
|
768,469 |
| Total assets |
3,788,309
|
3,623,676
|
3,439,426 |
| Current assets |
1,018,534
|
1,198,723
|
1,451,488 |
| Current liabilities |
1,456,951
|
2,180,601
|
1,939,308 |
| Equity capital |
640,031
|
307,426
|
661,277 |
| - share capital |
42,853
|
42,853
|
42,853 |
| Employees (average) |
350
|
350
|
350 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
16.9%
|
8.5%
|
19.2% |
| Turnover per employee |
5,761
|
5,979
|
7,194 |
| Profit as a percentage of turnover |
-7.2%
|
15.1%
|
30.5% |
| Return on assets (ROA) | |||
| Current ratio |
69.9%
|
55.0%
|
74.8% |
| Return on equity (ROE) |
-22.7%
|
102.8%
|
116.2% |
| Change turnover |
-76,371
|
-425,431
|
332,963 |
| Change turnover % |
-4%
|
-17%
|
15% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.